ID

21473

Beschreibung

Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00390806

Link

https://clinicaltrials.gov/show/NCT00390806

Stichworte

Versionen (1)
  1. 23.04.17 23.04.17 -
Hochgeladen am

23. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Lung Cancer, Non-Small Cell NCT00390806

Englisch

Eligibility Lung Cancer, Non-Small Cell NCT00390806

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
at least one measurable cancerous lesion in the brain from primary non-small cell lung cancer (nsclc)
Beschreibung

Measurable Disease Malignant Quantity Brain | Non-Small Cell Lung Carcinoma Primary

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0205282
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0006104
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C0205225
must have received previous chemotherapy
Beschreibung

Chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
must be 18 years of age of greater
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
must be easter cooperative oncology group (ecog) performance status 0, 1, 2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
at least 2 weeks must have elapsed since any surgery
Beschreibung

Operative Surgical Procedures Elapsed Time

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C2826303
at least 4 weeks must have elapsed since any radiation to a non-cns site
Beschreibung

Therapeutic radiology procedure Site outside Central Nervous System | Elapsed Time

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C1515974
UMLS CUI [1,3]
C0205101
UMLS CUI [1,4]
C3714787
UMLS CUI [2]
C2826303
must have adequate bone marrow, renal, and live capacities
Beschreibung

Bone Marrow function | Renal function | Liver function

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
women must be of non-childbearing potential or practice adequate birth control
Beschreibung

Childbearing Potential Absent | Childbearing Potential Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
males must practice adequate methods of birth control
Beschreibung

Gender Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
must sign written informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous whole brain radiation therapy
Beschreibung

Whole brain radiotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C1520143
prior treatment with topotecan
Beschreibung

Topotecan

Datentyp

boolean

Alias
UMLS CUI [1]
C0146224
investigational agent within 30 days or 5 half-live
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
concomitant therapy with inhibitors of breast cancer resistance protein (bcrp) or p-glycoprotein such as erlotinib or gefitinib
Beschreibung

Breast Cancer Resistance Protein Inhibitors | P-Glycoprotein | erlotinib | gefitinib

Datentyp

boolean

Alias
UMLS CUI [1]
C3819035
UMLS CUI [2]
C0242643
UMLS CUI [3]
C1135135
UMLS CUI [4]
C1122962
primary or secondary immunodeficiencies
Beschreibung

Primary immunodeficiency | Secondary immunodeficiency

Datentyp

boolean

Alias
UMLS CUI [1]
C0398686
UMLS CUI [2]
C0398795
gastrointestinal conditions that affect gi absorption or motility
Beschreibung

Gastrointestinal Disease Affecting Gastrointestinal Absorption | Gastrointestinal Disease Affecting Gastrointestinal Motility

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0017178
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C3714657
UMLS CUI [2,1]
C0017178
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0017184
uncontrolled emesis
Beschreibung

Uncontrolled Vomiting

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0205318
UMLS CUI [1,2]
C0042963
brain metastasis at time of initial diagnosis of nsclc
Beschreibung

Metastatic malignant neoplasm to brain | Initial diagnosis Non-Small Cell Lung Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2,1]
C4071762
UMLS CUI [2,2]
C0007131
history of other malignancy except in situ carcinoma of cervix; nonmelanomatous skin cancer, low grade prostate cancer
Beschreibung

Malignant Neoplasms | Carcinoma in situ of uterine cervix | Skin carcinoma | Prostate carcinoma low grade

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0851140
UMLS CUI [3]
C0699893
UMLS CUI [4,1]
C0600139
UMLS CUI [4,2]
C1282907
pregnant or intending to become pregnant or intending to father a baby
Beschreibung

Pregnancy | Pregnancy, Planned | Reproduction intended

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3,1]
C0035150
UMLS CUI [3,2]
C1283828
any severe concurrent medical condition that could affect compliance.
Beschreibung

Comorbidity Affecting Compliance behavior

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C1321605
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Lung Cancer, Non-Small Cell NCT00390806

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Measurable Disease Malignant Quantity Brain | Non-Small Cell Lung Carcinoma Primary
Item
at least one measurable cancerous lesion in the brain from primary non-small cell lung cancer (nsclc)
boolean
C1513041 (UMLS CUI [1,1])
C0205282 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0006104 (UMLS CUI [1,4])
C0007131 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
Chemotherapy
Item
must have received previous chemotherapy
boolean
C0392920 (UMLS CUI [1])
Age
Item
must be 18 years of age of greater
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
must be easter cooperative oncology group (ecog) performance status 0, 1, 2
boolean
C1520224 (UMLS CUI [1])
Operative Surgical Procedures Elapsed Time
Item
at least 2 weeks must have elapsed since any surgery
boolean
C0543467 (UMLS CUI [1,1])
C2826303 (UMLS CUI [1,2])
Therapeutic radiology procedure Site outside Central Nervous System | Elapsed Time
Item
at least 4 weeks must have elapsed since any radiation to a non-cns site
boolean
C1522449 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
C0205101 (UMLS CUI [1,3])
C3714787 (UMLS CUI [1,4])
C2826303 (UMLS CUI [2])
Bone Marrow function | Renal function | Liver function
Item
must have adequate bone marrow, renal, and live capacities
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Childbearing Potential Absent | Childbearing Potential Contraceptive methods
Item
women must be of non-childbearing potential or practice adequate birth control
boolean
C3831118 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Gender Contraceptive methods
Item
males must practice adequate methods of birth control
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Informed Consent
Item
must sign written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Whole brain radiotherapy
Item
previous whole brain radiation therapy
boolean
C1520143 (UMLS CUI [1])
Topotecan
Item
prior treatment with topotecan
boolean
C0146224 (UMLS CUI [1])
Investigational New Drugs
Item
investigational agent within 30 days or 5 half-live
boolean
C0013230 (UMLS CUI [1])
Breast Cancer Resistance Protein Inhibitors | P-Glycoprotein | erlotinib | gefitinib
Item
concomitant therapy with inhibitors of breast cancer resistance protein (bcrp) or p-glycoprotein such as erlotinib or gefitinib
boolean
C3819035 (UMLS CUI [1])
C0242643 (UMLS CUI [2])
C1135135 (UMLS CUI [3])
C1122962 (UMLS CUI [4])
Primary immunodeficiency | Secondary immunodeficiency
Item
primary or secondary immunodeficiencies
boolean
C0398686 (UMLS CUI [1])
C0398795 (UMLS CUI [2])
Gastrointestinal Disease Affecting Gastrointestinal Absorption | Gastrointestinal Disease Affecting Gastrointestinal Motility
Item
gastrointestinal conditions that affect gi absorption or motility
boolean
C0017178 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C3714657 (UMLS CUI [1,3])
C0017178 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0017184 (UMLS CUI [2,3])
Uncontrolled Vomiting
Item
uncontrolled emesis
boolean
C0205318 (UMLS CUI [1,1])
C0042963 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain | Initial diagnosis Non-Small Cell Lung Carcinoma
Item
brain metastasis at time of initial diagnosis of nsclc
boolean
C0220650 (UMLS CUI [1])
C4071762 (UMLS CUI [2,1])
C0007131 (UMLS CUI [2,2])
Malignant Neoplasms | Carcinoma in situ of uterine cervix | Skin carcinoma | Prostate carcinoma low grade
Item
history of other malignancy except in situ carcinoma of cervix; nonmelanomatous skin cancer, low grade prostate cancer
boolean
C0006826 (UMLS CUI [1])
C0851140 (UMLS CUI [2])
C0699893 (UMLS CUI [3])
C0600139 (UMLS CUI [4,1])
C1282907 (UMLS CUI [4,2])
Pregnancy | Pregnancy, Planned | Reproduction intended
Item
pregnant or intending to become pregnant or intending to father a baby
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0035150 (UMLS CUI [3,1])
C1283828 (UMLS CUI [3,2])
Comorbidity Affecting Compliance behavior
Item
any severe concurrent medical condition that could affect compliance.
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video